Development, worsening, and improvement of diabetic microangiopathy in older people: Six-year prospective study of patients under intensive diabetes control

Journal of the American Geriatrics Society

Volumn 55, Issue 4, 2007, Pages 541-547

  Katakura, Masafumi ^a   Naka, Motoji ^b   Kondo, Teruki ^c   Komatsu, Mitsuhisa ^d   Yamauchi, Keishi ^d   Hashizume, Kiyoshi ^d   Aizawa, Toru ^d  

^a Chikuma Chuo Hospital   (Japan)

^b Asama General Hospital   (Japan)

^c Nagano Chuo Hospital   (Japan)

^d SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Diabetes mellitus; Hyperglycemia; Hypertension; Nephropathy; Retinopathy

Indexed keywords

CHOLESTEROL; CREATININE; HEMOGLOBIN A1C; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

AGED; ARTICLE; BLOOD PRESSURE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORRELATION COEFFICIENT; CREATININE BLOOD LEVEL; DIABETES CONTROL; DIABETIC MICROANGIOPATHY; DIABETIC NEPHROPATHY; DIABETIC RETINOPATHY; DISEASE COURSE; DISEASE EXACERBATION; FEMALE; GERIATRIC PATIENT; GLOMERULUS FILTRATION RATE; HOSPITALIZATION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERGLYCEMIA; INTENSIVE CARE; INTERVENTION STUDY; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBSERVATIONAL STUDY; PATHOGENESIS; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; STROKE; SYSTOLIC BLOOD PRESSURE;

AGED; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; DIABETIC RETINOPATHY; FEMALE; HUMANS; HYPERGLYCEMIA; HYPERTENSION; HYPOGLYCEMIC AGENTS; LOGISTIC MODELS; MALE; PROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 33947721860     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/j.1532-5415.2007.01122.x     Document Type: Article

References (35)

1. Hogikyan R, Halter JB. Aging and Diabetes. In: Porte D Jr, Sherwin RS, Baron A, eds. Ellenberg and Rifkin's Diabetes Mellitus, 6th Ed. New York: McGraw-Hill, 2003, pp 415-424.
2. American Diabetes Association. Clinical Practice Recommendations 2005. Diabetes Care 2005;28(Suppl 1):S1-S79.
3. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-986.
4. UK Prospective Diabetes Study Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352:837-853.
5. Ohkubo Y, Kishikawa H, Araki E et al. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: A randomized prospective 6-year study. Diabetes Res Clin Pract 1995;28:103-117.
6. Gaede P, Vedel P, Parving HH et al. Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: The Steno type 2 randomised study. Lancet 1999;353:617-622.
7. Sakharova OV, Inzucchi SE. Treatment of diabetes in the elderly- Addressing its complexities in this high-risk group. Postgrad Med 2005;118:19-29.
8. Brown AF, Mangione CM, Saliba D et al. California Healthcare Foundation/American Geriatrics Society Panel on Improving Care for Elders with Diabetes: Guidelines for improving the care of the older person with diabetes mellitus. J Am Geriatr Soc 2003;51:S265-S280.
9. Kuusisto J, Mykkanen L, Pyorala K et al. NIDDM and its metabolic control predict coronary heart disease in elderly subjects. Diabetes 1994;43:960-967.
10. Kuusisto J, Mykkanen L, Pyorala K et al. Non-insulin-dependent diabetes and its metabolic control are important predictors of stroke in elderly subjects. Stroke 1994;25:1157-1164.
11. Araki A, Ito H, Hattori A et al. Risk factors for development of retinopathy in elderly Japanese patients with diabetes mellitus. Diabetes Care 1993;16:1184-1186.
12. Morisaki N, Watanabe S, Kobayashi J et al. Diabetic control and progression of retinopathy in elderly patients: Five-year follow-up study. J Am Geriatr Soc 1994;42:142-145.
13. Tanaka Y, Atsumi Y, Matsuoka K et al. Role of glycemic control and blood pressure in the development and progression of nephropathy in elderly Japanese NIDDM patients. Diabetes Care 1998;21:116-120.
14. Narita T, Kakei M, Ito S. Aggressive antihypertensive treatment and serum lipid lowering therapy are necessary to prevent deterioration of the renal function even in elderly type 2 diabetic patients with persistent albuminuria. Gerontology 2002;48:302-308.
15. Katakura M, Naka M, Kondo T et al. Prospective analysis of mortality, morbidity, and risk factors in elderly diabetic subjects: Nagano study. Diabetes Care 2003;26:638-644.
16. Araki A, Murotani Y, Kamimiya F et al. Low well-being is an independent predictor for stroke in elderly patients with diabetes mellitus. J Am Geriatr Soc 2004;52:205-210.
17. Diabetes Mellitus. Report of a WHO Study Group (Technical Report Series no. 727). Geneva, Switzerland: World Heath Organization, 1985.
18. Katakura M, Naka M, Kondo T et al. Normal mortality in the elderly with diabetes under strict glycemic and blood pressure control: outcome of 6-year prospective study. Diabetes 2005;54(Suppl 1):A244 (Abstract #998).
19. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502.
20. Levey AS, Bosch JP, Lewis JB et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999;130:461-470.
21. Levey AS, Greene T, Kusek JW et al. A simplified equation to predict glomerular filtration rate from serum creatinine. J Am Soc Nephrol 2000;11:155A (Abstract #0828).
22. Hoelzel W, Weykamp C, Jeppsson JO et al. IFCC reference system for measurement of hemoglobin A1c in human blood and the national standardization schemes in the United States, Japan, and Sweden: A method-comparison study. Clin Chem 2004;50:166-174.
23. Klein R, Klein BE, Moss SE et al. The Wisconsin Epidemiologic Study of diabetic retinopathy. XIV. Ten-year incidence and progression of diabetic retinopathy. Arch Ophthalmol 1994;112:1217-1228.
24. Parving HH, Lehnert H, Brochner-Mortensen J et al. The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes. N Engl J Med 2001;345:870-887.
25. Parving HH, Hovind P, Rossing K et al. Evolving strategies for renoprotection: Diabetic nephropathy. Curr Opin Nephrol Hypertens 2001;10:515-522.
26. Ravid M, Brosh D, Ravid-Safran D et al. Main risk factors for nephropathy in type 2 diabetes mellitus are plasma cholesterol levels, mean blood pressure, and hyperglycemia. Arch Intern Med 1998;158:998-1004.
27. Chaturvedi N, Fuller JH, Taskinen MR. EURODIAB PCS Group. Differing associations of lipid and lipoprotein disturbances with the macrovascular and microvascular complications of type 1 diabetes. Diabetes Care 2001;24:2071-2077.
28. Araki S, Haneda M, Sugimoto T et al. Factors associated with frequent remission of microalbuminuria in patients with type 2 diabetes. Diabetes 2005;54:2983-2987.
29. Yamada T, Komatsu M, Komiya I et al. Development, progression, and regression of microalbuminuria in Japanese patients with type 2 diabetes under tight glycemic and blood pressure control: The Kashiwa study. Diabetes Care 2005;28:2733-2738.
30. Klein R, Klein BE, Moss SE et al. Is blood pressure a predictor of the incidence or progression of diabetic retinopathy? Arch Intern Med 1989;149:2427-2432.
31. Ayodele OE, Alebiosu CO, Salako BL. Diabetic nephropathy - a review of the natural history, burden, risk factors and treatment. J Natl Med Assoc 2004;96:1445-1454.
32. Orth SR. Smoking - a renal risk factor. Nephron 2000;86:12-26.
33. Aizawa T, Kobayashi M, Sato Y et al. Possible link between a low prevalence of cardiovascular disease and mild dyslipidaemia: A study in Japanese patients with type 2 diabetes. Diabet Med 1993;10:431-437.
34. Katakura M, Komatsu M, Sato Y et al. Primacy of β-cell dysfunction in the development of hyperglycemia: A study in the Japanese general population. Metabolism 2004;53:949-953.
35. West KM, Ahuja MM, Bennett PH et al. The role of circulating glucose and triglyceride concentrations and their interactions with other 'risk factors' as determinants of arterial disease in nine diabetic population samples from the WHO multinational study. Diabetes Care 1983;6:361-369.